Metraipolis › archive › dc_50e42cefeb48

Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study — Europe PMC PMID:36758101

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36758101
DOI
10.1371/journal.pntd.0010938
License (as archived)
CC0-1.0
Archived
2026-10-07T17:03:49.442Z
SHA-256 of the archived text
3b4172a9e93cf9784faa3bf6c483de028feb81392904cf43af54892e6e70ac31
Stable URL of this page
https://metraipolis.com/documento/dc_50e42cefeb48

How to cite

Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study — Europe PMC PMID:36758101 — Europe PMC (en), https://europepmc.org/article/MED/36758101 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_50e42cefeb48 (Metraipolis archive dc_50e42cefeb48, sha256 3b4172a9e93cf9784faa3bf6c483de028feb81392904cf43af54892e6e70ac31)
BibTeX
@misc{dc50e42cefeb48,
  title = {Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study — Europe PMC PMID:36758101},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36758101},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_50e42cefeb48; sha256 3b4172a9e93cf9784faa3bf6c483de028feb81392904cf43af54892e6e70ac31},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36758101. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Lassa virus (LASV), the cause of the acute viral hemorrhagic illness Lassa fever (LF), is endemic in West Africa. Infections in humans occur mainly after exposure to infected excrement or urine of the rodent-host, Mastomys natalensis. The prevalence of exposure to LASV in Sierra Leone is crudely estimated and largely unknown. This cross-sectional study aimed to establish a baseline point seroprevalence of IgG antibodies to LASV in three administrative districts of Sierra Leone and identify potential risk factors for seropositivity and LASV exposure. Methodology and principal findings: Between 2015 and 2018, over 10,642 participants from Kenema, Tonkolili, and Port Loko Districts were enrolled in this cross-sectional study. Previous LASV and LF epidemiological studies support classification of these districts as "endemic," "emerging," and "non-endemic", respectively. Dried blood spot samples were tested for LASV antibodies by ELISA to determine the seropositivity of participants, indicating previous exposure to LASV. Surveys were administered to each participant to assess demographic and environmental factors associated with a higher risk of exposure to LASV. Overall seroprevalence for antibodies to LASV was 16.0%. In Kenema, Port Loko, and Tonkolili Districts, seroprevalences were 20.1%, 14.1%, and 10.6%, respectively. In a multivariate analysis, individuals were more likely to be LASV seropositive if they were living in Kenema District, regardless of sex, age, or occupation. Environmental factors contributed to an increased risk of LASV exposure, including poor housing construction and proximity to bushland, forested areas, and refuse. Conclusions and significance: In this study we determine a baseline LASV seroprevalence in three districts which will inform future epidemiological, ecological, and clinical studies on LF and the LASV in Sierra Leone. The heterogeneity of the distribution of LASV and LF over both space, and time, can make the design of efficacy trials and intervention programs difficult. Having more studies on the prevalence of LASV and identifying potential hyper-endemic areas will greatly increase the awareness of LF and improve targeted control programs related to LASV.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2023 (prima pubblicazione 2023-02-09).
Identificativi: PMID 36758101 · PMCID PMC9946222 · DOI 10.1371/journal.pntd.0010938.
Descrittori MeSH principali: Virus Diseases; Lassa Fever.
Pagina: https://europepmc.org/article/MED/36758101 — https://doi.org/10.1371/journal.pntd.0010938. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T16:33:59.640Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.